ASM Technologies Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 20, 2025, 7:36 pm

Quick Insight

ASM Technologies Ltd, a player in the IT Consulting & Software industry, is currently trading at a price of 2,629 with a market capitalization of 3,095 Cr. The company's high P/E ratio of 79.9 indicates investor optimism about future growth potential, supported by a solid Return on Equity (ROE) of 16.5% and Return on Capital Employed (ROCE) of 19.6%. With a healthy Operating Profit Margin (OPM) of 22% and a robust Net Profit of 25 Cr, ASM Technologies has shown resilience. However, the high Price-to-Book Value (P/BV) ratio of 9.16x suggests the stock may be overvalued. Additionally, the company's leverage with borrowings of ₹86 Cr warrants monitoring for financial health. In conclusion, while ASM Technologies displays strong financial performance, investors should be cautious of its valuation and debt levels.

Competitors of ASM Technologies Ltd

All Competitor Stocks of ASM Technologies Ltd

Quarterly Result

Last Updated: August 19, 2025, 11:05 pm

Below is a detailed analysis of the quarterly data for ASM Technologies Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 123.00 Cr.. The value appears strong and on an upward trend. It has increased from 115.00 Cr. (Mar 2025) to 123.00 Cr., marking an increase of 8.00 Cr..
• For Expenses, as of Jun 2025, the value is 97.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 89.00 Cr. (Mar 2025) to 97.00 Cr., marking an increase of 8.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 1.00 Cr..
• For OPM %, as of Jun 2025, the value is 21.00%. The value appears to be declining and may need further review. It has decreased from 22.00% (Mar 2025) to 21.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Mar 2025) to 3.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 22.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 1.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Mar 2025) to 27.00%, marking a decrease of 2.00%.
• For Net Profit, as of Jun 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 1.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 13.23. The value appears strong and on an upward trend. It has increased from 13.04 (Mar 2025) to 13.23, marking an increase of 0.19.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:49 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:48 pm

Below is a detailed analysis of the balance sheet data for ASM Technologies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Reserves, as of Mar 2025, the value is 153.00 Cr.. The value appears strong and on an upward trend. It has increased from 130.00 Cr. (Mar 2024) to 153.00 Cr., marking an increase of 23.00 Cr..
• For Borrowings, as of Mar 2025, the value is 86.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 82.00 Cr. (Mar 2024) to 86.00 Cr., marking an increase of 4.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 35.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Mar 2024) to 35.00 Cr., marking an increase of 21.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 287.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 238.00 Cr. (Mar 2024) to 287.00 Cr., marking an increase of 49.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 76.00 Cr.. The value appears strong and on an upward trend. It has increased from 49.00 Cr. (Mar 2024) to 76.00 Cr., marking an increase of 27.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 28.00 Cr. (Mar 2024) to 29.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 182.00 Cr.. The value appears strong and on an upward trend. It has increased from 162.00 Cr. (Mar 2024) to 182.00 Cr., marking an increase of 20.00 Cr..
• For Total Assets, as of Mar 2025, the value is 287.00 Cr.. The value appears strong and on an upward trend. It has increased from 238.00 Cr. (Mar 2024) to 287.00 Cr., marking an increase of 49.00 Cr..

Notably, the Reserves (153.00 Cr.) exceed the Borrowings (86.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for ASM Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 21.13. This value is within the healthy range. It has increased from -6.74 (Mar 24) to 21.13, marking an increase of 27.87.
• For Diluted EPS (Rs.), as of Mar 25, the value is 21.13. This value is within the healthy range. It has increased from -6.69 (Mar 24) to 21.13, marking an increase of 27.82.
• For Cash EPS (Rs.), as of Mar 25, the value is 29.49. This value is within the healthy range. It has increased from 3.70 (Mar 24) to 29.49, marking an increase of 25.79.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 139.03. It has increased from 115.54 (Mar 24) to 139.03, marking an increase of 23.49.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 139.03. It has increased from 115.54 (Mar 24) to 139.03, marking an increase of 23.49.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 243.17. It has increased from 171.27 (Mar 24) to 243.17, marking an increase of 71.90.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 47.23. This value is within the healthy range. It has increased from 9.17 (Mar 24) to 47.23, marking an increase of 38.06.
• For PBIT / Share (Rs.), as of Mar 25, the value is 38.93. This value is within the healthy range. It has increased from -0.38 (Mar 24) to 38.93, marking an increase of 39.31.
• For PBT / Share (Rs.), as of Mar 25, the value is 28.82. This value is within the healthy range. It has increased from -8.82 (Mar 24) to 28.82, marking an increase of 37.64.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 21.19. This value is within the healthy range. It has increased from -5.86 (Mar 24) to 21.19, marking an increase of 27.05.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 22.08. This value is within the healthy range. It has increased from -3.64 (Mar 24) to 22.08, marking an increase of 25.72.
• For PBDIT Margin (%), as of Mar 25, the value is 19.42. This value is within the healthy range. It has increased from 5.35 (Mar 24) to 19.42, marking an increase of 14.07.
• For PBIT Margin (%), as of Mar 25, the value is 16.00. This value is within the healthy range. It has increased from -0.22 (Mar 24) to 16.00, marking an increase of 16.22.
• For PBT Margin (%), as of Mar 25, the value is 11.85. This value is within the healthy range. It has increased from -5.15 (Mar 24) to 11.85, marking an increase of 17.00.
• For Net Profit Margin (%), as of Mar 25, the value is 8.71. This value is within the healthy range. It has increased from -3.42 (Mar 24) to 8.71, marking an increase of 12.13.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.08. This value is within the healthy range. It has increased from -2.12 (Mar 24) to 9.08, marking an increase of 11.20.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.88. This value is within the healthy range. It has increased from -3.03 (Mar 24) to 15.88, marking an increase of 18.91.
• For Return on Capital Employeed (%), as of Mar 25, the value is 24.77. This value is within the healthy range. It has increased from -0.25 (Mar 24) to 24.77, marking an increase of 25.02.
• For Return On Assets (%), as of Mar 25, the value is 9.14. This value is within the healthy range. It has increased from -1.80 (Mar 24) to 9.14, marking an increase of 10.94.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.19 (Mar 24) to 0.05, marking a decrease of 0.14.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.46. This value is within the healthy range. It has decreased from 0.48 (Mar 24) to 0.46, marking a decrease of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.10. It has increased from 0.99 (Mar 24) to 1.10, marking an increase of 0.11.
• For Current Ratio (X), as of Mar 25, the value is 1.78. This value is within the healthy range. It has decreased from 2.34 (Mar 24) to 1.78, marking a decrease of 0.56.
• For Quick Ratio (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has decreased from 2.28 (Mar 24) to 1.59, marking a decrease of 0.69.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.34. This value is within the healthy range. It has increased from 5.32 (Mar 24) to 5.34, marking an increase of 0.02.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -102.58 (Mar 24) to 0.00, marking an increase of 102.58.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 63.16 (Mar 24) to 0.00, marking a decrease of 63.16.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 202.58 (Mar 24) to 0.00, marking a decrease of 202.58.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 36.84 (Mar 24) to 0.00, marking a decrease of 36.84.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.77. This value is within the healthy range. It has increased from 1.09 (Mar 24) to 4.77, marking an increase of 3.68.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.16. This value is within the healthy range. It has increased from 0.30 (Mar 24) to 3.16, marking an increase of 2.86.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,576.05. It has increased from 1,039.26 (Mar 24) to 1,576.05, marking an increase of 536.79.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.46. This value exceeds the healthy maximum of 3. It has increased from 5.15 (Mar 24) to 5.46, marking an increase of 0.31.
• For EV / EBITDA (X), as of Mar 25, the value is 28.09. This value exceeds the healthy maximum of 15. It has decreased from 96.24 (Mar 24) to 28.09, marking a decrease of 68.15.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.24. This value exceeds the healthy maximum of 3. It has increased from 5.20 (Mar 24) to 5.24, marking an increase of 0.04.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 202.58 (Mar 24) to 0.00, marking a decrease of 202.58.
• For Price / BV (X), as of Mar 25, the value is 9.16. This value exceeds the healthy maximum of 3. It has increased from 7.41 (Mar 24) to 9.16, marking an increase of 1.75.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.24. This value exceeds the healthy maximum of 3. It has increased from 5.20 (Mar 24) to 5.24, marking an increase of 0.04.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness